We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
-21.51%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$8.43B
AUM Growth
-$8.39B
(-50%)
Cap. Flow
-$5.17B
Cap. Flow
% of AUM
-61.29%
Top 10 Holdings %
Top 10 Hldgs %
10.82%
Holding
1,704
New
583
Increased
218
Reduced
300
Closed
598
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$109M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$89.4M |
| 3 |
JPMorgan Chase
JPM
|
+$82.7M |
| 4 |
Intel
INTC
|
+$73.6M |
| 5 |
Boston Scientific
BSX
|
+$72.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American International
AIG
|
+$193M |
| 2 |
RTX Corp
RTX
|
+$170M |
| 3 |
PNC Financial Services
PNC
|
+$126M |
| 4 |
ExxonMobil
XOM
|
+$121M |
| 5 |
Bank of America
BAC
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.11% |
| 2 | Technology | 13.97% |
| 3 | Financials | 13.54% |
| 4 | Consumer Discretionary | 12.99% |
| 5 | Industrials | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Inogen
INGN
$158M
| $6.26M | 0.07% |
121,196
-21,557
| -15% | -$1.04M |
|
|
AMRN
352
Amarin Corp
AMRN
$298M
| $6.21M | 0.07% |
77,605
+57,136
| +279% | +$19M |
|
353
Cencora
COR
$63.1B
| $6.15M | 0.07% |
69,470
+46,751
| +206% | +$4.12M |
|
354
Westlake Corp
WLK
$10.3B
| $6.15M | 0.07% |
+161,056
| New | +$9.05M |
|
355
CALL
Iovance Biotherapeutics
IOVA
$2.91B
| $6.14M | 0.07% |
+205,200
| New | +$5.44M |
|
|
PSB
356
DELISTED
PS Business Parks, Inc.
PSB
| $6.13M | 0.07% |
+45,197
| New | +$7.03M |
|
357
Norfolk Southern
NSC
$75.1B
| $6.11M | 0.07% |
41,825
-100,261
| -71% | -$18.5M |
|
358
CALL
AbbVie
ABBV
$439B
| $6.09M | 0.07% |
+80,000
| New | +$6.81M |
|
359
BioCryst Pharmaceuticals
BCRX
$2.67B
| $6.01M | 0.07% |
+3,005,676
| New | +$8.28M |
|
360
AMN Healthcare
AMN
$1.32B
| $6M | 0.07% |
103,850
+65,032
| +168% | +$4.45M |
|
361
Dick's Sporting Goods
DKS
$18.5B
| $5.95M | 0.07% |
+280,066
| New | +$10.7M |
|
362
HP
HPQ
$26.6B
| $5.95M | 0.07% |
342,894
-171,219
| -33% | -$3.46M |
|
|
RAD
363
DELISTED
Rite Aid Corporation
RAD
| $5.94M | 0.07% |
+395,715
| New | +$5.54M |
|
364
News Corp Class A
NWSA
$15.5B
| $5.92M | 0.07% |
659,500
-576,228
| -47% | -$7.27M |
|
|
AIMT
365
DELISTED
Aimmune Therapeutics
AIMT
| $5.91M | 0.07% |
409,576
+196,274
| +92% | +$5.02M |
|
366
Cushman & Wakefield Ltd
CWK
$3.18B
| $5.87M | 0.07% |
499,741
-69,750
| -12% | -$1.2M |
|
367
Natera
NTRA
$45.7B
| $5.81M | 0.07% |
194,614
+182,741
| +1,539% | +$6.11M |
|
368
PUT
Caterpillar
CAT
$392B
| $5.8M | 0.07% |
+50,000
| New | +$6.39M |
|
369
Lear
LEA
$8.12B
| $5.8M | 0.07% |
71,408
-190,487
| -73% | -$21.9M |
|
370
ScottsMiracle-Gro
SMG
$3.61B
| $5.75M | 0.07% |
+56,131
| New | +$6.17M |
|
371
PUT
Agilent Technologies
A
$42.2B
| $5.73M | 0.07% |
80,000
+30,000
| +60% | +$2.41M |
|
372
Manulife Financial
MFC
$73.2B
| $5.72M | 0.07% |
456,128
-886,765
| -66% | -$15.4M |
|
373
Yum China
YUMC
$16.2B
| $5.68M | 0.07% |
+133,165
| New | +$5.94M |
|
374
Sun Communities
SUI
$14.5B
| $5.63M | 0.07% |
45,074
-27,352
| -38% | -$4.13M |
|
375
Performance Food Group
PFGC
$17.9B
| $5.62M | 0.07% |
227,137
-147,830
| -39% | -$6.36M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q1 2020 Portfolio in Review
As of Q1 2020, Balyasny Asset Management held 1,704 positions worth $8.43B, down 50% from $16.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Balyasny Asset Management withdrew a net $5.17B in Q1 2020, closing 598 positions and reducing 300 holdings. Its most notable exit was American International, an estimated $193M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 10% a quarter earlier, followed by Technology and Financials.
Against the trend, Balyasny Asset Management opened a new position in Lowe's Companies worth $86M.
- Balyasny Asset Management's largest Q1 2020 buy was Lowe's Companies: 999,686 shares worth $86M.
- Balyasny Asset Management added most to Boston Scientific in Q1 2020, an estimated $72.4M increase.
- Balyasny Asset Management's biggest Q1 2020 reduction was ExxonMobil, cutting an estimated $121M.
- Balyasny Asset Management fully exited American International in Q1 2020, selling an estimated $193M.
- Balyasny Asset Management's ten largest holdings make up 11% of its $8.43B portfolio in Q1 2020.
- Balyasny Asset Management opened 583 new positions and closed 598 in Q1 2020.
- Balyasny Asset Management's portfolio value fell 50% quarter-over-quarter to $8.43B.
Based on Balyasny Asset Management's 13F filing for Q1 2020, filed 15 May 2020.